Sionna Therapeutics, Inc. · NASDAQ:SION
Viking Global Investors LP reported a 6.70% stake in Sionna Therapeutics, Inc. (Schedule 13G)
Event Feb 10, 2025 · Filed Feb 14, 2025
Viking Global Investors LP reported a 6.70% stake in Sionna Therapeutics, Inc., 2,952,754 shares, as a passive investor on Feb 10, 2025. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 2,952,754
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 6.70% | 2,952,754 |
| Viking Global Opportunities Parent GP LLC | 6.70% | 2,952,754 |
| Viking Global Opportunities GP LLC | 4.30% | 1,894,346 |
| Viking Global Opportunities Portfolio GP LLC | 4.30% | 1,894,346 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 4.30% | 1,894,346 |
| Viking Global Opportunities Drawdown GP LLC | 2.40% | 1,058,408 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 2.40% | 1,058,408 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 2.40% | 1,058,408 |
| HALVORSEN OLE ANDREAS | 6.70% | 2,952,754 |
| Ott David C. | 6.70% | 2,952,754 |
| Shabet Rose Sharon | 6.70% | 2,952,754 |
Source
Related
- Sionna Therapeutics, Inc.
- Viking Global Investors LP
- Sionna Therapeutics, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Form 4 · Ra Capital Management, L.P. · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 21, 2026
- Form 4 · Ridloff Elena · Sep 18, 2026
- Form 4 · McKee Charlotte · Sep 18, 2026
- Form 4 · Fitzpatrick Jennifer · Sep 18, 2026